Home
Events
-
May 5 – 6, 2026Bioequivalence Innovations for Oral Generic Products: Biowaivers, Bridging, and Generic Development for Oncology and Discontinued Products
Bioequivalence Innovations for Oral Generic Products: Biowaivers, Bridging, and Generic Development for Oncology and Discontinued Products -
Sep 23 – 24, 2026Navigating the GLP-1 Generic Pathway: From Peptide to Patient
Navigating the GLP-1 Generic Pathway: From Peptide to Patient -
Oct 14 – 15, 2026Advancing Bioequivalence Frameworks for Inhalation and Nasal Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods
Advancing Bioequivalence Frameworks for Inhalation and Nasal Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods